Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

Market Cap	11.14B
Revenue (ttm)	1.53B
Net Income (ttm)	429.67M
Shares Out	1.25B
EPS (ttm)	0.34
PE Ratio	26.32
Forward PE	24.75
Dividend	0.12 (1.35%)
Ex-Dividend Date	May 29, 2025

Volume	5,565,300
Average Volume	28,459,145
Open	8.90
Previous Close	8.91
Day's Range	8.90 - 9.05
52-Week Range	5.32 - 12.75
Beta	0.15
RSI	39.02
Earnings Date	Oct 30, 2025

About SHE:002550

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials. It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium. The company ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1971
• Employees: 979
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002550

Financial Performance

In 2024, SHE:002550's revenue was 1.53 billion, a decrease of -15.88% compared to the previous year's 1.81 billion. Earnings were 356.03 million, an increase of 95.77%.